Long-Term Changes in Hepatic Fibrosis following Hepatitis C Viral Clearance in Patients with and without HIV | Zendy

Julia B. Balmaceda | Zendy; Julia Aepfelbacher | Zendy; Olivia Belliveau | Zendy; Chloe S Chaudhury | Zendy; Cheryl Chairez | Zendy; Mary McLaughlin | Zendy; Rachel Silk | Zendy; Chloe Gross | Zendy; Sarah Kattakuzhy | Zendy; Elana Rosenthal | Zendy; Shyam Kottilil | Zendy; David E. Kleiner | Zendy; Colleen Hadigan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Changes in Hepatic Fibrosis following Hepatitis C Viral Clearance in Patients with and without HIV

Author(s) -

Julia B. Balmaceda,

Julia Aepfelbacher,

Olivia Belliveau,

Chloe S Chaudhury,

Cheryl Chairez,

Mary McLaughlin,

Rachel Silk,

Chloe Gross,

Sarah Kattakuzhy,

Elana Rosenthal,

Shyam Kottilil,

David E. Kleiner,

Colleen Hadigan

Publication year - 2018

Publication title -

antiviral therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 87

eISSN - 2040-2058

pISSN - 1359-6535

DOI - 10.3851/imp3327

Subject(s) - medicine , steatosis , transient elastography , fibrosis , hepatic fibrosis , gastroenterology , coinfection , liver biopsy , body mass index , hepatitis c , population , logistic regression , biopsy , immunology , human immunodeficiency virus (hiv) , liver fibrosis , environmental health

While acute changes in hepatic fibrosis are recognized shortly after achieving sustained virological response (SVR) using direct-acting antiviral therapies, long-term outcomes for the growing population of successfully treated patients with HCV remain uncertain. The aim of this study is to characterize long-term changes in fibrosis following SVR in patients with and without HIV and to identify potential factors associated with progression or regression of fibrosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research